搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
1 小时
on MSN
Weight loss drugs are more likely to be covered on government-funded insurance than on ...
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...
1 小时
‘Human fuel’ maker triples profits on Ozempic boom
Huel counts Jonathan Ross and the actor Idris Elbas among its investors, alongside Steven Bartlett, the podcaster and former Dragons’ Den investor who also sits on the company’s board. Adverts for ...
1 小时
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Benefits Pro
3 小时
Pharmacies lobby FDA for right to keep making weight-loss drugs
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
BioSpace
3 小时
Novo’s Wegovy Launched in China at a Fraction of US Price
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...
STAT
3 小时
Pharmalittle: We’re reading about RFK Jr. and vaccines, obesity-drug prescribing for kids ...
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...
bnnbloomberg
6 小时
Novo Nordisk Launches Wegovy in China With Prices Well Below US
Ozempic, a drug which contains the same active ingredient of semaglutide, was approved in 2021 and subsequently included on ...
7 小时
Exclusive-Medicaid Fuels US Coverage of Novo, Lilly Weight-Loss Drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
ENDPOINTS NEWS
7 小时
Are programs with compounded GLP-1s safe for your population?
Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...
Opinion
8 小时
Opinion
Saving Endangered Animals Will Help Save Us, Too
We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...
8 小时
Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈